Insmed reported $15.41B in Market Capitalization this May of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
BioMarin Pharmaceutical USD 10.18B 683M May/2026
Cytokinetics USD 9.16B 975M May/2026
DBV Technologies USD 274M 17M Sep/2025
Gilead Sciences USD 167.39B 5.6B May/2026
Heron Therapeutics USD 238M 7M Dec/2025
Insmed USD 15.56B 19.73B May/2026
Regeneron Pharmaceuticals USD 81.68B 560M Mar/2026
Sarepta Therapeutics USD 2.16B 123M May/2026
Ultragenyx Pharmaceutical USD 2.06B 1000K May/2026
Vertex Pharmaceuticals USD 113.58B 1000K May/2026